2,325
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation

, , , , , , , , , , , , , , , , , , , & show all
Pages 1840-1853 | Received 07 Jul 2020, Accepted 14 Sep 2020, Published online: 12 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Terungwa H. Iorkula, Bryce A. Tolman, Scott R. Burt & Matt A. Peterson. (2024) An efficient synthesis of C-6 aminated 3-bromoimidazo[1,2-b]pyridazines. Synthetic Communications 54:2, pages 121-132.
Read now
Sreenivas Avula, Xudan Peng, Xingfen Lang, Micky Tortorella, Béatrice Josselin, Stéphane Bach, Stephane Bourg, Pascal Bonnet, Frédéric Buron, Sandrine Ruchaud, Sylvain Routier & Cleopatra Neagoie. (2022) Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1632-1650.
Read now

Articles from other publishers (8)

Linyun Tan, Yitian Wang, Xin Hu, Guifeng Du, Xiaodi Tang & Li Min. (2023) Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine. Biomolecules 13:9, pages 1362.
Crossref
Eun-Ji Kwon, Karishma K. Mashelkar, Juhee Seo, Yoon-Ze Shin, Kisu Sung, Sung Chul Jang, Sang Won Cheon, Haeseung Lee, Hyuk Woo Lee, Gyudong Kim, Byung Woo Han, Sang Kook Lee, Lak Shin Jeong & Hyuk-Jin Cha. (2023) In Silico Discovery of 5′-Modified 7-Deoxy-7-ethynyl-4′-thioadenosine as a HASPIN Inhibitor and Its Synergistic Anticancer Effect with the PLK1 Inhibitor. ACS Central Science 9:6, pages 1140-1149.
Crossref
Y.-Y. Hou, W.-J. Ye, S.-S. Wang, F. Wu, C.-S. Zhao & Z.-X. Zhou. (2023) Synthesis, Crystal Structure, and DFT Study of Ethyl 6-Chloro-3-fluoroimidazo[1,2-b]pyridazine-2-carboxylate. Russian Journal of General Chemistry 93:5, pages 1193-1200.
Crossref
Yongjian Liu, Hongliu Yang, Yongsheng Fang, Yantao Xing, Xinxin Pang, Yang Li, Yuanyuan Zhang & Yonggang Liu. (2023) Function and inhibition of Haspin kinase: targeting multiple cancer therapies by antimitosis. Journal of Pharmacy and Pharmacology 75:4, pages 445-465.
Crossref
Simon Garnier, Kévin Brugemann, Agnieszka Zak, Johnny Vercouillie, Marie Potier-Cartereau, Mathieu Marchivie, Sylvain Routier & Frédéric Buron. (2022) A Facile One-Pot Synthesis of New Poly Functionalized Pyrrolotriazoles via a Regioselective Multicomponent Cyclisation and Suzuki–Miyaura Coupling Reactions. Catalysts 12:8, pages 828.
Crossref
Wael Zeinyeh, Yannick J. Esvan, Béatrice Josselin, Mathilde Defois, Blandine Baratte, Stefan Knapp, Apirat Chaikuad, Fabrice Anizon, Francis Giraud, Sandrine Ruchaud & Pascale Moreau. (2022) Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity. European Journal of Medicinal Chemistry 236, pages 114369.
Crossref
Ahmed El Akkaoui, Jamal Koubachi, Gérald Guillaumet & Saïd El Kazzouli. (2021) Synthesis and Functionalization of Imidazo[1,2‐ b ]Pyridazine by Means of Metal‐Catalyzed Cross‐Coupling Reactions . ChemistrySelect 6:34, pages 8985-9011.
Crossref
Rakesh Kumar Sharma, Manisha Singh, Khagendra Ghimeray, Pinky Juneja, Gagan Dev, Sridhar Pulavarthi, Sabbasani Rajasekhara Reddy & Ravi Shankar Akundi. (2021) Imidazopyridazine Acetylcholinesterase Inhibitors Display Potent Anti-Proliferative Effects in the Human Neuroblastoma Cell-Line, IMR-32. Molecules 26:17, pages 5319.
Crossref